在COVID-19中,高凝固性表型的丧失,临床特征和补充途径消耗之间的关联
Daisuke Kasugai1, Taku Tanaka1, Takako Suzuki2
1Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Frontiers in immunology
|March 26, 2024
概括
在严重的COVID-19中,高凝血状态与更好的结果相关,而正常凝血状态表明预后不佳. 了解这些凝血动态对于治疗呼吸系统疾病患者至关重要.
科学领域:
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
- 免疫学 免疫学 免疫学
背景情况:
- 新冠病毒病2019 (COVID-19) 与高凝血状态有关.
- 抗凝血疗法的有效性因COVID-19的严重程度而异.
- 凝血特征的动态及其与疾病严重程度和结果的联系需要进一步研究.
研究的目的:
- 为了评估COVID-19患者需要呼吸支持的凝血概况的动态.
- 评估凝血状态与COVID-19严重程度,患者结果和生物标志物轨迹之间的关联.
- 与疾病严重程度和恢复相关的凝血表型的特征.
主要方法:
- 这是一项多中心,前性,观察性研究,涉及166名需要呼吸支持的COVID-19患者.
- 旋转性血小板测试用于评估凝血和纤维素分解.
- 收集了纵向实验室参数,以定义凝血表型.
主要成果:
- 与非侵入性氧气患者相比,重病患者表现出较高的最大凝块弹性和较低的最大溶解.
- 超凝固的表型与重病患者 (15天 vs. 27天) 的更快恢复有关.
- 在严重的COVID-19中,一个正常凝固的表型与补充替代途径激活和较差的结果相关.
结论:
- 高凝血状态随着COVID-19呼吸系统疾病严重程度的增加而加剧.
- 在严重的COVID-19中,一种正常凝固的表型与替代补充路径激活和不良结果有关.
- 凝血标志物的动态与补体系统激活和膜损伤标志物相互联系.
关键词:
在 COVID-19 疫情中,替代补充途径是一种替代补充途径.血液凝固障碍 血液凝固障碍微血栓形成的微血栓形成旋转性血栓弹性测试 (Thromboelastometry) 是一种旋转性血栓弹性测试.更多相关视频
04:56Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
744
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11.8K
相关概念视频
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.5K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
01:24Disorders of Hemostasis
885
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
885
01:26Factors Affecting the Risk of Infection
11.8K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K
01:09Coagulation
6.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.5K
01:36Humoral Immune Responses
72.7K
Overview
72.7K